サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1429644

スマートインスリンペンの世界市場レポート2024

Smart Insulin Pens Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
スマートインスリンペンの世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

スマートインスリンペンの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.4%の年間複合成長率（CAGR）で1億3,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、病気の負担の増加、政府の取り組み、技術の向上に関連している可能性があります。予測期間中に予想される主な動向には、テクノロジー企業との提携、スマートインスリン投与装置の出現、新しいタイプのインスリン投与の進歩、モノのインターネットの統合、合併と買収の増加が含まれます。

バイアルや注射器と比較して、インスリンペンを使用すると、正確なインスリン投与量を達成することが可能になります。授業時間中にインスリンが必要な子供や視覚障害のある糖尿病患者などのシナリオでは、インスリンペンを使用すると、投与量ダイヤル上で正確な用量を事前設定できるため、注射時に正確な投与が保証されます。ノボノルディスクのEcho Plusなどの小児に優しいインスリンペンでは、最大30ユニットまでの半分のユニットの投与が可能です。 LillyのHumaPen Luxura HDなどの他のオプションでは、ハーフユニット単位でのインスリン投与が可能であり、ノボノルディスクのNovoPen Juniorでは、ハーフユニット単位での微調整も可能な高精度のインスリン投与量を提供します。 スマートインスリンペンによって提供される用量調整と投与の正確さにより、過剰投与と過小投与の両方を防ぐことができ、スマートインスリンペンの予想される需要の増加に貢献し、市場の成長を促進します。

スマートインスリンペン市場の予想される成長は、世界の糖尿病人口の増加によって推進されています。この集団は、血糖値の上昇を特徴とする慢性病状である糖尿病と診断された人々で構成されています。 スマートインスリンペンは、正確なインスリン投与量の追跡、リマインダー、データ統合を提供することで糖尿病管理を強化し、それによって糖尿病患者の治療アドヒアランスと全体的な血糖コントロールを向上させます。 2021年 12月の時点で、国際糖尿病連盟は、世界中で5億3,700万人の成人（20～79歳）が糖尿病に罹患していると報告しました。予測によれば、この数は2030年までに6億4,300万人に増加し、2045年までに合計 7億8,300万人に達するとされています。その結果、世界の糖尿病人口の増加がスマートインスリンペン市場の成長の主要な原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のスマートインスリンペン市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 第1世代ペン
  • 第2世代ペン（Bluetooth対応、USB接続）
  • 世界のスマートインスリンペン市場、ユーザビリティ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • プレフィルド
  • 再利用可能
  • 世界のスマートインスリンペン市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 1型糖尿病
  • 2型糖尿病
  • 世界のスマートインスリンペン市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院とクリニック
  • 外来手術センター
  • 在宅ケア環境

第7章 地域および国の分析

  • 世界のスマートインスリンペン市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のスマートインスリンペン市場、国別、実績および予測、2018年から2023年、2023年から2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • スマートインスリンペン市場の競合情勢
  • スマートインスリンペン市場の企業プロファイル
    • Companion Medical
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Emperra GmbH E-Health Technologies
    • Diamesco Co. Ltd.

第31章 その他の大手および革新的な企業

  • Digital Medics Pvt Ltd.
  • Bigfoot Biomedical
  • Diabnext
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co. Ltd.
  • Sanofi India
  • Becton Dickinson
  • Roche
  • Biocon Ltd
  • Mehar healthcare
  • Johnson &Johnson
  • GE Healthcare
  • Covidien Healthcare
  • Philips Healthcare India
  • Shandong WeiGao Group Medical Polymer Company Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14615

Smart insulin pens refer to insulin delivery devices designed to monitor and record dosage information, including volume, time, and type. Additionally, these devices may offer functionalities such as generating reports for sharing with healthcare professionals.

Two primary types of smart insulin pens exist first-generation pens and second-generation pens (equipped with Bluetooth or USB connectivity). Second-generation smart insulin pens incorporate Bluetooth or USB features to facilitate closer monitoring. These pens come in either prefilled or reusable forms and are utilized for the treatment of both type 1 diabetes and type 2 diabetes. Smart insulin pens find application across various end-users, including hospitals and clinics, ambulatory surgical centers, as well as home care settings.

The smart insulin pens market research report is one of a series of new reports from The Business Research Company that provides smart insulin pens market statistics, including smart insulin pens industry global market size, regional shares, competitors with a smart insulin pens market share, detailed smart insulin pens market segments, market trends and opportunities, and any further data you may need to thrive in the smart insulin pens industry. This smart insulin pens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart insulin pens market size has grown strongly in recent years. It will grow from $0.1 billion in 2023 to $0.1 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The historical period's growth can be ascribed to a rise in the prevalence of diabetes, robust economic expansion in emerging markets, an increased geriatric population, elevated healthcare expenditure, and reforms in public health insurance.

The smart insulin pens market size is expected to see strong growth in the next few years. It will grow to $0.13 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be linked to an increase in the disease burden, government initiatives, and technological enhancements. Major trends expected in the forecast period involve collaborations with technology companies, the emergence of smart insulin delivery devices, advancements in new types of insulin delivery, the integration of the Internet of Things, and a rise in mergers and acquisitions.

Achieving an accurate dose of insulin is more feasible with an insulin pen compared to a vial or syringe. For scenarios such as children requiring insulin during school hours and visually impaired diabetic patients, the insulin pen allows for pre-setting an accurate dose over the dosage dial, ensuring precise delivery at the time of injection. Pediatric-friendly insulin pens such as Novo Nordisk's Echo Plus enable half-unit dosing, with a maximum of 30 units. Other options such as Lilly's HumaPen Luxura HD allow insulin delivery in half-unit increments, and Novo Nordisk's NovoPen Junior offers highly accurate insulin doses, finely adjusting even in half-unit increments. The precision in dose adjustments and delivery offered by smart insulin pens can prevent both over-dosing and under-dosing, contributing to the expected increase in demand for smart insulin pens and driving market growth.

The anticipated growth of the smart insulin pen market is propelled by the increasing global diabetic population. This population comprises individuals diagnosed with diabetes, a chronic medical condition characterized by elevated blood glucose levels. Smart insulin pens enhance diabetes management by providing precise insulin dosage tracking, reminders, and data integration, thereby improving treatment adherence and overall glycemic control for individuals with diabetes. As of December 2021, the International Diabetes Federation reported that diabetes affected 537 million adults (20-79 years old) globally. Projections indicate that this number will rise to 643 million by 2030 and reach a total of 783 million by 2045. Consequently, the increasing global diabetic population is a key driver for the growth of the smart insulin pen market.

The next generation of smart insulin pens extends beyond simple memory storage capabilities. These advanced devices not only calculate personalized doses but also continuously track glucose levels and integrate with smartphone apps to visualize data. An example of such innovation is the Mallya smart insulin pen device, a collaboration between Biocorp and Roche Diabetes Care France, launched in France in April 2021. The Mallya device is designed to enhance the daily routines of diabetes patients by collecting and storing crucial treatment data, including insulin units, injection dates, and times. The collected data is seamlessly transmitted to a dedicated mobile app, providing both patients and healthcare professionals with convenient access for real-time monitoring and management.

Major companies in the smart insulin pens market are strategically focusing on introducing user-friendly insulin pens, such as the NovoPen 6 and the NovoPen Echo Plus, to optimize revenue in the market. These self-injection pens automatically record insulin dosing information for each injection. For instance, in March 2022, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched the first smart insulin pens-NovoPen 6 and NovoPen Echo Plus. These pens record details such as the timing and quantity of insulin administered, uploading the data to an app via near-field communication (NFC). The pens facilitate the transfer of insulin dosing information to a patient's preferred diabetes app, allowing data sharing with healthcare providers. They are compatible with smartphones, tablets, personal computers, blood glucose monitors, or other NFC-supported devices.

In October 2023, Novo Nordisk A/S acquired Biocorp, a France-based medical device company specializing in the development and manufacturing of drug-delivery systems and medical devices, for $164.5 million. This acquisition is expected to enable Novo Nordisk to further invest in Biocorp's device development and expedite its ambitions within devices and delivery solutions.

Major companies operating in the smart insulin pens market report are Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Emperra GmbH E-Health Technologies, Diamesco Co. Ltd., Digital Medics Pvt Ltd., Bigfoot Biomedical, Diabnext, Insulet Corporation, Jiangsu Delfu Medical Device Co. Ltd., Sanofi India, Becton Dickinson, Roche, Biocon Ltd., Mehar healthcare, Johnson & Johnson, GE Healthcare, Covidien Healthcare, Philips Healthcare India, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Terumo, NIPRO, Olympus Medical Systems, Hitachi Medico, Nihon Koden, Fukuda Denshi, Medtronic, Ypsomed Holding AG, Berlin-Chemie AG, Patients Pending Ltd., Dexcom, Ok biotech, Insujet, Eli Lilly., Abbott Laboratories, Acon Laboratories, Tandem Diabetes Care, Inc.

North America was the largest region in the smart insulin pens market in 2023. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in the smart insulin pens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart insulin pens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The smart insulins pens market consists of sales of instruments such as first-generation pens and second-generation pens (Bluetooth enabled, USB connected). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Insulin Pens Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart insulin pens market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart insulin pens? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart insulin pens market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: First Generation Pens; Second Generation Pens
  • 2) By Usability: Prefilled; Reusable
  • 3) By Application: Type 1 Diabetes; Type 2 Diabetes
  • 4) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Home Care Settings
  • Companies Mentioned: Companion Medical; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Emperra GmbH E-Health Technologies; Diamesco Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Insulin Pens Market Characteristics

3. Smart Insulin Pens Market Trends And Strategies

4. Smart Insulin Pens Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Insulin Pens Market Size and Growth

  • 5.1. Global Smart Insulin Pens Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Insulin Pens Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Insulin Pens Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Insulin Pens Market Segmentation

  • 6.1. Global Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • First Generation Pens
  • Second Generation Pens (Bluetooth Enabled, USB Connected)
  • 6.2. Global Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prefilled
  • Reusable
  • 6.3. Global Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • 6.4. Global Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

7. Smart Insulin Pens Market Regional And Country Analysis

  • 7.1. Global Smart Insulin Pens Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Insulin Pens Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Insulin Pens Market

  • 8.1. Asia-Pacific Smart Insulin Pens Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Insulin Pens Market

  • 9.1. China Smart Insulin Pens Market Overview
  • 9.2. China Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Insulin Pens Market

  • 10.1. India Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Insulin Pens Market

  • 11.1. Japan Smart Insulin Pens Market Overview
  • 11.2. Japan Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Insulin Pens Market

  • 12.1. Australia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Insulin Pens Market

  • 13.1. Indonesia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Insulin Pens Market

  • 14.1. South Korea Smart Insulin Pens Market Overview
  • 14.2. South Korea Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Insulin Pens Market

  • 15.1. Western Europe Smart Insulin Pens Market Overview
  • 15.2. Western Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Insulin Pens Market

  • 16.1. UK Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Insulin Pens Market

  • 17.1. Germany Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Insulin Pens Market

  • 18.1. France Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Insulin Pens Market

  • 19.1. Italy Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Insulin Pens Market

  • 20.1. Spain Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Insulin Pens Market

  • 21.1. Eastern Europe Smart Insulin Pens Market Overview
  • 21.2. Eastern Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Insulin Pens Market

  • 22.1. Russia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Insulin Pens Market

  • 23.1. North America Smart Insulin Pens Market Overview
  • 23.2. North America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Insulin Pens Market

  • 24.1. USA Smart Insulin Pens Market Overview
  • 24.2. USA Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Insulin Pens Market

  • 25.1. Canada Smart Insulin Pens Market Overview
  • 25.2. Canada Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Insulin Pens Market

  • 26.1. South America Smart Insulin Pens Market Overview
  • 26.2. South America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Insulin Pens Market

  • 27.1. Brazil Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Insulin Pens Market

  • 28.1. Middle East Smart Insulin Pens Market Overview
  • 28.2. Middle East Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Insulin Pens Market

  • 29.1. Africa Smart Insulin Pens Market Overview
  • 29.2. Africa Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Insulin Pens Market Competitive Landscape And Company Profiles

  • 30.1. Smart Insulin Pens Market Competitive Landscape
  • 30.2. Smart Insulin Pens Market Company Profiles
    • 30.2.1. Companion Medical
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novo Nordisk A/S
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Emperra GmbH E-Health Technologies
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Diamesco Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Smart Insulin Pens Market Other Major And Innovative Companies

  • 31.1. Digital Medics Pvt Ltd.
  • 31.2. Bigfoot Biomedical
  • 31.3. Diabnext
  • 31.4. Insulet Corporation
  • 31.5. Jiangsu Delfu Medical Device Co. Ltd.
  • 31.6. Sanofi India
  • 31.7. Becton Dickinson
  • 31.8. Roche
  • 31.9. Biocon Ltd
  • 31.10. Mehar healthcare
  • 31.11. Johnson & Johnson
  • 31.12. GE Healthcare
  • 31.13. Covidien Healthcare
  • 31.14. Philips Healthcare India
  • 31.15. Shandong WeiGao Group Medical Polymer Company Limited

32. Global Smart Insulin Pens Market Competitive Benchmarking

33. Global Smart Insulin Pens Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Insulin Pens Market

35. Smart Insulin Pens Market Future Outlook and Potential Analysis

  • 35.1 Smart Insulin Pens Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Smart Insulin Pens Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Smart Insulin Pens Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer